Healthcare News

Browse the latest Healthcare news, including Healthcare Providers, Medical Equipment, Medical Supplies and Services, Biotechnology and Pharmaceuticals, and Cannabis industries. Use the menu or navigation tiles to get to specific industries within each sector.

January 22, 2026 09:28 ET | Source: Tilray Brands, Inc.

Tilray Medical stärkt die Marktpräsenz in Italien mit der Gründung von Tilray Medical Italia und einem erweiterten Portfolio an medizinischen Cannabis-Produkten

NEW YORK und SAVONA, Italien, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray“) (Nasdaq: TLRY; TSX: TLRY) und ein weltweit führender Anbieter...
January 22, 2026 09:28 ET | Source: Tilray Brands, Inc.

Tilray Medical renforce sa présence sur le marché italien avec le lancement de Tilray Medical Italia et l’élargissement de son portefeuille de produits à base de cannabis thérapeutique

NEW YORK et SAVONE, Italie, 22 janv. 2026 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (« Tilray ») (Nasdaq : TLRY ; TSX : TLRY) et leader mondial du cannabis...
January 22, 2026 09:25 ET | Source: Polyrizon Ltd.

Polyrizon Advances Regulatory Path with Initiation of Usability Study Program for NASARIX™ Allergy Blocker

Executed in accordance with FDA human factors and usability engineering guidance, the study is intended to de-risk downstream regulatory review and support a streamlined path toward clinical...
January 22, 2026 09:15 ET | Source: Pluri Inc.

Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials

HAIFA, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a biotechnology company leveraging its proprietary platform for cell-based...
January 22, 2026 09:00 ET | Source: Human Continuum Inc.

Human Continuum Appoints Dr. Omar Khalid Sial, Ph.D., as its Chief Scientific Officer to Spearhead the Development of Innovative Extracellular Vesicle Topical Formulations and Advanced Biologic Therapies

New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced...
January 22, 2026 09:00 ET | Source: Kaida Biopharma

Kaida BioPharma Appoints Co-Founder Dr. Stella K. Vnook as Chairperson of the Board

Appointment aligns Board leadership with Company’s transition to clinical-stage development and advancement of KAD-101 for platinum-resistant ovarian cancer Company advancing KAD-101, a...
January 22, 2026 09:00 ET | Source: Roji Health Intelligence

Roji Health Intelligence Re-Certified as CMS Qualified Registry for 2026

CMS re-certifies Roji Health Intelligence as a Qualified Registry for 2026 as reporting demands and financial risk rise for providers.
January 22, 2026 09:00 ET | Source: SPR Therapeutics, Inc.

SPR Announces Eight Featured Posters and Presentations at NANS 2026

SPR to feature eight abstracts on SPRINT PNS at the 2026 North American Neuromodulation Society (NANS) Annual Meeting in Las Vegas.
January 22, 2026 08:45 ET | Source: Cannabix Technologies Inc.

Cannabix Marijuana Breath Test Featured on the Cover of AlcoPro’s 2026 Product Catalog

VANCOUVER, British Columbia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) a developer of marijuana and...
January 22, 2026 08:45 ET | Source: PDS Biotechnology Corporation

PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101

PRINCETON, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...